NEW YORK (Reuters Health) – Concerns that bisphosphonate drugs used to treat osteoporosis might increase the risk of developing esophageal cancer have been put to rest by a…
NEW YORK (Reuters Health) – Patients who have undergone prior systemic therapies for cutaneous T-cell lymphoma may respond well to treatment with romidepsin, a potent inhibitor of histone…
NEW YORK (Reuters Health) – The response rate with standard treatment of hepatitis C infection is doubled when a hepatitis C virus (HCV) protease inhibitor, boceprevir, is added…
NEW YORK (Reuters Health) – When target cholesterol levels are not achieved with statin monotherapy in patients with mixed dyslipidemia, adding fenofibrate can tip the scales favorably. Dr.…
NEW YORK (Reuters Health) – Patients on warfarin need not discontinue treatment when they have a fecal occult blood test (FOBT), as it does not affect the predictive…
NEW YORK (Reuters Health) – Contrary to earlier concerns, the use of ultrasound contrast agents in echocardiography is not associated with an increased incidence of myocardial infarction or…
NEW YORK (Reuters Health) – For selected patients with locally advanced or metastatic non-small-cell lung cancer, a split course of radiation given over a short period works well…
NEW YORK (Reuters Health) – Cardioversion of atrial fibrillation or flutter to sinus rhythm using ibutilide is more successful and less likely to trigger torsades de pointes when…
NEW YORK (Reuters Health) – Epileptic seizures in children can be terminated at home just as well with intranasal midazolam as with rectal diazepam, a comparison study shows.…
NEW YORK (Reuters Health) – For children with type 1 diabetes being treated with an insulin pump, lowering the basal insulin rate after exercise reduces the occurrence of…